Throughout the COVID‑19 pandemic, Washington State University pharmacy students were on the frontline, helping to test for the virus thanks in part to legislation they helped pass in 2019.
A $2.1 million grant from the National Institutes of Health will allow Washington State University researchers to take the next steps toward blocking transmission of Lyme disease and anaplasmosis.
A new method for generating potent, specific binding proteins yields candidate medicines for cancer, diabetes, inflammation and more.
Discovery that Lamin B1 mutation causes odd-shaped nuclei may lead to improved leukemia care.
UW Medicine’s contribution to finishing the sequence covered highly repetitive regions, include those related to human evolution.
Carrying behaviors differ from those seen among urban youths, offering more specific context to firearm-prevention programs.
MRI demonstrate that the amygdala grows too rapidly between 6 and 12 months of age, before characteristics of autism fully emerge
The study's lead author expresses surprise that patients still under the care of cancer specialists would forgo these diagnostic exams.
A one-shot vaccine schedule could contribute greatly to the elimination of cervical cancer worldwide, researchers say.
Providing artificial intelligence tools with the data they need takes time. How much time do first responders have to spare? ¬50 seconds.
If resource shortages became dire, triage team members would have to deprioritize some patients from getting life-sustaining care.
The finding supports theory that genetic differences between individuals and species can affect the acquisition of mutations.
Creating a novel population of mutant tissues helps scientists deduce the cause of polycystic kidney disease and other cilia-linked illnesses.
Project aims to create a genome reference that represents the genetic diversity of all the populations on Earth.
Findings indicate unexplained disparities at screening sites influence the lag in follow-ups among nonwhite women, authors say.
A new study published today in the American Journal of Obstetrics and Gynecology shows a mother-to-be's COVID-19 infection can impair her placena's immune response, leaving it vulnerable to other viruses and infections during pregnancy.
This damage occurs even if the mother has a mild case of COVID-19, OB-GYN researchers found.
SKbioscience’s SKYCovione vaccine becomes the first therapeutic OK'd for people to emerge from the Institute for Protein Design.
Project explores whether simple interventions can lower use of medications that increase fall risk in this population.
The impact is greater on a male fetus. The UW Medicine-led study encourages pregnant women to be tested for stress levels.